Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).
Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Listen it here.
Los próximos 3, 4 y 5 de mayo tendrán lugar el VII Simposium Internacional de la EPOC y Tabaco y el XVII Simposium Internacional sobre prevención y tratamiento del tabaquismo.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
El pasado mes de febrero la UB celebró en su sala Paraninfo La “Barcelona Boston Lung Conference”, un foro anual de debate científico al más alto nivel sobre diversos aspectos de las enfermedades respiratorias, con un elenco de ponentes del máximo nivel internacional.
Àlvar Agustí ha participado en este evento como miembro del comité científico de la reunión, resaltando la importancia de “pasar de una medicina reactiva a una medicina predictiva…»
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
Patients with COPD can have acute episodes of worsening symptoms, known generically as exacerbations, which are clinically relevant because they involve an acute deterioration of the patient’s health status, worsen the patient’s prognosis, and are the main cause of economic expenditure associated with COPD.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively.
